Dechra Veterinary Products Limited (A business unit of Dechra Pharmaceuticals PLC) Sansaw Business Park Hadnall, Shrewsbury Shropshire SY4 4AS Tel: 01939 211200 CANAURAL® EAR DROPS, SUSPENSION FOR
treatment period is prolonged, in vitro sensitivity
DOGS AND CATS Advice on correct administration: Official, national
Presentation
and regional antimicrobial policies should be taken
into account when the product is used. Contra-indications, warnings, etc
Do not use concomitantly with products known to
Do not use in animals with known hypersensitivity
Canaural® is effective against the micro-or-
to the active substances or to the excipient.
ganisms commonly associated with otitis externa,
Not recommended for use in pregnant animals.
including the ear mite, Otodectes cynotis, and is
Adverse reactions: Allergy or hypersensitivity reac-
specifically formulated for the treatment of otitis
tions to the active substances or the excipient might
Anti-inflammatory corticosteroids such as predni-
administration Where
solone are known to exert a wide range of side
prior to administration, the ear canal and the sur-
effects. Dosage in medium to long term use should
rounding area should be cleaned mechanically or by
therefore generally be kept to the minimum.
irrigation, taking care to avoid further damage to the
During therapy, effective doses suppress the hy-
skin. Any excess exudate, hair or debris should be
pothalamo-pituitreal-adrenal axis. Following cessa-
carefully removed prior to the application of the ear
tion of treatment symptoms of adrenal insufficiency
drops. Animal owners should only do this on the
can arise and this may render the animal unable to
direction of the prescribing veterinary surgeon.
deal adequately with stressful situations.
Corticosteroids may delay wound healing and the
Instil 5-10 drops into the ear according to the size of
immunosuppressant actions may weaken resistance
the animal and ear canal twice daily. Without allowing
to, or exacerbate existing infections.
the animal to shake its head, very gently massage the
If you notice any serious effects or other effects not
ear canal after administration holding the pinna in an
mentioned in the data sheet, please inform your
upright position to ensure penetration of the drops
Special precautions for use in animals: Following
Where ear mite infection is present, consideration
recovery the ears should be checked at regular
should be given to treating both ears, even if infection
intervals for any signs of re-infection.
is apparent in only one. Treatment should continue
Special precautions to be taken by the person
for at least 3 weeks to ensure that successive genera-
administering the veterinary medicinal product to
tions of ear mites are killed. Animals that are in
animals: Avoid skin contact with this product. Wash
hands thoroughly after applying the product.
Where treatment is for a period longer than 7 days,
In case of accidental eye contact, rinse thoroughly
regular clinical re-evaluation should be carried out.
Where Gram-negative infections are involved, the use
People with known hypersensitivity to any of the
of the veterinary medicinal product should be based
active substances or the excipient should avoid
on bacterial sensitivity testing. In cases where the
contact with the veterinary medicinal product. Special warnings: For animal treatment only.
For external use only. To be used under veterinary supervision. Further information
Not recommended for use in pregnant and lactating
the batch release: Dales Pharmaceuticals, Snaygill
Industrial Estate, Keighley Road, Skipton, North York-
Pharmaceutical precautions
25˚C. Protect from direct sunlight. Keep the bottle in
To be supplied only on veterinary prescription.
the outer carton. Keep out of the reach and sight of
Veterinary medicinal product authorised for use in
Do not use after the expiry date stated on the label
Shelf life after first opening the container: 3 months. Marketing authorisation holder (if different from
In order to calculate the date on which any product
distributor)
remaining in the bottle should be discarded, add 3
months to the date on which the bottle is opened forthe first time. This discard date should be written in
Marketing authorisation number Vm 24883/4004 Disposal: Dispose of any unused product and
empty containers in accordance with guidance from
GTIN (Global Trade Item No)
your local waste regulation authority.
Canaural Ear Drops, Suspension for Dogs and Cats15 ml 05055031500048
Legal category POM-V
Canaural Ear Drops, Suspension for Dogs and Cats
Packaging quantities
tles, supplied in boxes of 1 × 15 ml, 10 x 15 ml, 1 ×
Canaural Ear Drops, Suspension for Dogs and Cats
Requested by: [email protected] Approved datasheets found: 1 Creation date: 2/3/2011 13:42:49 (UK) Approved for book but not on website: 0 Datasheets marked as draft (ignored): 0
Canaural Ear Drops, Suspension for Dogs and
Directory of participants Dechra Veterinary Products Limited (A business unit of Dechra Pharmaceuticals PLC) Sansaw Business Park Hadnall, Shrewsbury Shropshire SY4 4AS Tel: 01939 211200Fax: 01939 211201email: [email protected]
LIST OF PRODUCTS BY THERAPEUTIC INDICATION
List of Products by Therapeutic Indication PHARMACEUTICALS Antimicrobials Topical preparations List of Products by Species
Please note that a species in brackets after a product name may not necessarily be a part of that product namebut is intended to make the index easier to use.
Canaural Ear Drops, Suspension for Dogs and
Canaural Ear Drops, Suspension for Dogs and
List of Products by Active Ingredients
This index of non-proprietary names (active ingredients) is provided to enable users of the Compendium toidentify the brand names of relevant products when only the non-proprietary names are known.
It should be noted that although different products may contain the same active ingredient this does not implythat they are equivalent in regard to bioavailability or therapeutic activity.
Some products contain a number of ingredients and it has not been possible in every instance to identify suchproducts by a reference in this index to each ingredient.
Non-proprietary name in bold type. Proprietary name in ordinary type. Diethanolamine Fusidate Nystatin
Canaural Ear Drops, Suspension for Dogs and
Canaural Ear Drops, Suspension for Dogs and
Framycetin Sulfate Prednisolone
Canaural Ear Drops, Suspension for Dogs and
Canaural Ear Drops, Suspension for Dogs and
GRED IN E IV Alphabetical Index of Products
UNITED STATES OF AMERICA BEFORE THE FEDERAL ENERGY REGULATORY COMMISSION MOTION TO ANSWER AND ANSWER OF EXELON TO THE IDAHO PUBLIC UTILITIES COMMISSION Pursuant to Commission Rules 212 and 213,1 Exelon Corporation (“Exelon”) submits this limited Answer to the Answer filed by the Idaho Public Utilities Commission (“Idaho PUC”) in this proceeding. Exelon submits that Ce
This article was downloaded by:[Pérez-López, Marcos]On: 25 June 2008Access Details: [subscription number 794430300]Publisher: Taylor & FrancisInforma Ltd Registered in England and Wales Registered Number: 1072954Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UKJournal of Environmental Science and Health, Part B Pesticides, Food Contaminants, and Agricultural Was